|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
|
US7374768B1
(en)
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
|
US6309647B1
(en)
*
|
1999-07-15 |
2001-10-30 |
Aventis Pasteur |
Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
|
|
EP0561034B1
(en)
*
|
1991-08-26 |
1999-06-09 |
IMMUNO Aktiengesellschaft |
Direct molecular cloning of a modified chordopox virus genome
|
|
EP0758397B1
(en)
*
|
1994-04-29 |
2005-06-22 |
Baxter Healthcare S.A. |
Recombinant poxviruses with foreign polynucleotides in essential regions
|
|
FR2750865B1
(fr)
*
|
1996-06-27 |
1998-12-04 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
|
|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
US6368603B1
(en)
*
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
FR2775601B1
(fr)
*
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
|
CA2388337C
(en)
*
|
1999-10-22 |
2013-01-08 |
Aventis Pasteur Limited |
Method of inducing and/or enhancing an immune response to tumor antigens
|
|
DK1248646T3
(da)
*
|
1999-12-21 |
2008-05-19 |
Merial Sas |
Præparater og vacciner indeholdende antigen(er) fra cryptosporidium parvum og fra andet enterisk patogen
|
|
US20030027246A1
(en)
*
|
2000-03-31 |
2003-02-06 |
Artur Pedyczak |
Immunogenic peptides derived from prostate-specific membrane antigen (PSMA) and uses thereof
|
|
EP1741782B1
(en)
|
2000-05-10 |
2011-06-22 |
Sanofi Pasteur Limited |
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
|
|
US7097842B2
(en)
*
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
US7628980B2
(en)
*
|
2000-11-23 |
2009-12-08 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
CA2421151C
(en)
|
2000-11-23 |
2013-07-02 |
Bavarian Nordic A/S |
Modified vaccinia ankara virus variant
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US20070269456A1
(en)
*
|
2001-11-05 |
2007-11-22 |
Lasher Alfred W |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
US20030228327A1
(en)
*
|
2001-11-05 |
2003-12-11 |
Lasher Alfred W. |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
IL163701A0
(en)
*
|
2002-04-19 |
2005-12-18 |
Bavarian Nordic As |
Modified vaccinia virus ankara for the vaccinationof neonates
|
|
JP2006511194A
(ja)
|
2002-05-02 |
2006-04-06 |
デイビッド ラブジョイ |
テネウリンｃ末端関連ペプチド（ｔｃａｐ）並びにこれらに関連する方法および使用
|
|
JP2005537793A
(ja)
*
|
2002-09-05 |
2005-12-15 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
無血清条件下で初代細胞を培養する方法及びウイルスを増幅させる方法
|
|
WO2004056977A1
(en)
*
|
2002-12-13 |
2004-07-08 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
|
AU2003297155B2
(en)
*
|
2002-12-16 |
2010-03-18 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant vaccine viruses expressing IL-15 and methods of using the same
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
WO2004110482A1
(en)
*
|
2003-06-13 |
2004-12-23 |
Isis Innovation Limited |
Improved vaccines
|
|
JP5576010B2
(ja)
|
2003-08-04 |
2014-08-20 |
ザ・ホスピタル・フォー・シック・チルドレン |
ラフォラ病遺伝子
|
|
CA2545886A1
(en)
|
2003-11-13 |
2005-06-02 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
WO2005118672A1
(en)
*
|
2004-06-02 |
2005-12-15 |
The Governors Of The University Of Alberta |
Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
|
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
CA2605629C
(en)
*
|
2005-04-25 |
2012-06-26 |
Merial Limited |
Nipah virus vaccines
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
CA2629522A1
(en)
|
2005-11-14 |
2007-05-18 |
Merial Limited |
Gene therapy for renal failure
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
BRPI0709282B8
(pt)
|
2006-03-29 |
2021-05-25 |
Merial Ltd |
vacina contra estreptococos
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
KR20150038558A
(ko)
*
|
2006-11-30 |
2015-04-08 |
탭이뮨, 인크. |
분자 아주반트로서 ｔａｐ―１ 및/또는 ｔａｐ―２를 포함하는 폭스비리대 치료
|
|
MX2009011851A
(es)
|
2007-05-02 |
2010-03-04 |
Merial Ltd |
Plasmidos de dna que tienen expresion y estabilidad mejoradas.
|
|
EP2283035B1
(en)
|
2008-05-08 |
2015-07-29 |
Merial Limited |
Leishmania vaccine using sand fly salivary immunogen
|
|
WO2009155711A1
(en)
|
2008-06-27 |
2009-12-30 |
University Of Guelph |
Analysis of lactobacillus acidophilus la-5 signal interference molecules
|
|
ES2681693T3
(es)
|
2008-10-24 |
2018-09-14 |
Merial, Inc. |
Vacuna contra el virus de la peste equina africana
|
|
WO2012129295A1
(en)
|
2011-03-21 |
2012-09-27 |
Vaxin Inc. |
Rapid and prolonged immunologic-therapeutic
|
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
ES2674439T3
(es)
|
2011-06-01 |
2018-06-29 |
Merial, Inc. |
Administración sin aguja de vacunas contra el VSRRP
|
|
PL2734230T3
(pl)
|
2011-07-20 |
2019-07-31 |
Merial Limited |
Rekombinowana szczepionka przeciwko wirusowi białaczki kotów zawierająca zoptymalizowany gen otoczki wirusa białaczki kotów
|
|
EA031229B1
(ru)
|
2011-08-12 |
2018-12-28 |
Мериал, Инк. |
Способ витрификации биологического материала
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
ES2723273T3
(es)
|
2012-02-14 |
2019-08-23 |
Merial Inc |
Vectores poxvirales recombinantes que expresan proteínas de la rabia y OX40 y vacunas fabricadas a partir de los mismos
|
|
NZ700470A
(en)
|
2012-03-20 |
2016-04-29 |
Merial Inc |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
|
WO2013142965A1
(en)
|
2012-03-27 |
2013-10-03 |
The University Of Western Ontario |
Sh2 domain variants
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
WO2014141244A1
(en)
|
2013-03-12 |
2014-09-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Synthetic peptides for the treatment of autoimmune diseases
|
|
WO2016073410A1
(en)
|
2014-11-03 |
2016-05-12 |
Merial, Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
EP3042666A1
(en)
|
2015-01-06 |
2016-07-13 |
Rheinisch-Westfälische Technische Hochschule Aachen |
ITIH5 fragments for the treatment of cancer
|
|
DK3288546T3
(da)
|
2015-04-28 |
2022-01-24 |
Avivagen Inc |
Oxiderede karotinoider og bestanddele deraf til forebyggelse af nekrotisk enteritis
|
|
TW202203966A
(zh)
*
|
2020-03-31 |
2022-02-01 |
澳大利亞商賽門蒂斯公司 |
用於防範ｃｏｖｉｄ－１９之以減毒的痘病毒載體為底質之疫苗
|
|
CN116656730B
(zh)
*
|
2023-05-25 |
2024-03-19 |
军事科学院军事医学研究院军事兽医研究所 |
一种表达狂犬病病毒g、m蛋白的重组金丝雀痘病毒及其构建方法
|